nodes	percent_of_prediction	percent_of_DWPC	metapath
Imiquimod—CYP3A4—Felbamate Metabolism—CYP2E1—Parkinson's disease	0.0475	0.0475	CbGpPWpGaD
Imiquimod—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Parkinson's disease	0.0171	0.0171	CbGpPWpGaD
Imiquimod—CYP1A2—Aflatoxin B1 metabolism—GSTM1—Parkinson's disease	0.0171	0.0171	CbGpPWpGaD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—MAPK8—Parkinson's disease	0.0145	0.0145	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—MAPK8—Parkinson's disease	0.0142	0.0142	CbGpPWpGaD
Imiquimod—CYP1A2—Methylation—COMT—Parkinson's disease	0.0141	0.0141	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—IL1B—Parkinson's disease	0.0138	0.0138	CbGpPWpGaD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—MAPK8—Parkinson's disease	0.0137	0.0137	CbGpPWpGaD
Imiquimod—CYP3A4—Aflatoxin B1 metabolism—GSTM1—Parkinson's disease	0.0132	0.0132	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—PLA2G6—Parkinson's disease	0.0129	0.0129	CbGpPWpGaD
Imiquimod—CYP1A2—Fatty Acid Omega Oxidation—CYP2D6—Parkinson's disease	0.0127	0.0127	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—MAPK8—Parkinson's disease	0.0126	0.0126	CbGpPWpGaD
Imiquimod—CYP3A4—Codeine and Morphine Metabolism—ABCB1—Parkinson's disease	0.0122	0.0122	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—FGF20—Parkinson's disease	0.0117	0.0117	CbGpPWpGaD
Imiquimod—CYP1A2—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.0117	0.0117	CbGpPWpGaD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—MAPK8—Parkinson's disease	0.011	0.011	CbGpPWpGaD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—MAPK8—Parkinson's disease	0.0108	0.0108	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—IL1B—Parkinson's disease	0.0108	0.0108	CbGpPWpGaD
Imiquimod—CYP1A2—Xenobiotics—CYP2D6—Parkinson's disease	0.0107	0.0107	CbGpPWpGaD
Imiquimod—CYP1A2—Estrogen metabolism—NQO1—Parkinson's disease	0.0105	0.0105	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—IL1B—Parkinson's disease	0.0104	0.0104	CbGpPWpGaD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—MAPK8—Parkinson's disease	0.0104	0.0104	CbGpPWpGaD
Imiquimod—CYP1A2—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.0103	0.0103	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—TNF—Parkinson's disease	0.01	0.01	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—MAPK8—Parkinson's disease	0.00987	0.00987	CbGpPWpGaD
Imiquimod—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Parkinson's disease	0.00983	0.00983	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—PLA2G6—Parkinson's disease	0.00977	0.00977	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—MAPK8—Parkinson's disease	0.00976	0.00976	CbGpPWpGaD
Imiquimod—CYP1A2—Xenobiotics—CYP2E1—Parkinson's disease	0.00975	0.00975	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—MAPK8—Parkinson's disease	0.00958	0.00958	CbGpPWpGaD
Imiquimod—CYP1A2—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.00938	0.00938	CbGpPWpGaD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—Parkinson's disease	0.00925	0.00925	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—IL6—Parkinson's disease	0.00908	0.00908	CbGpPWpGaD
Imiquimod—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—Parkinson's disease	0.00899	0.00899	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—FGF20—Parkinson's disease	0.00884	0.00884	CbGpPWpGaD
Imiquimod—CYP1A2—Estrogen metabolism—COMT—Parkinson's disease	0.00879	0.00879	CbGpPWpGaD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—IL6—Parkinson's disease	0.00877	0.00877	CbGpPWpGaD
Imiquimod—CYP1A2—Tryptophan metabolism—DDC—Parkinson's disease	0.00875	0.00875	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—ADRBK1—Parkinson's disease	0.00857	0.00857	CbGpPWpGaD
Imiquimod—TLR8—Immune System—DCTN1—Parkinson's disease	0.00834	0.00834	CbGpPWpGaD
Imiquimod—CYP3A4—Xenobiotics—CYP2D6—Parkinson's disease	0.00823	0.00823	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—IL1B—Parkinson's disease	0.00816	0.00816	CbGpPWpGaD
Imiquimod—CYP3A4—Estrogen metabolism—NQO1—Parkinson's disease	0.00809	0.00809	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—IL6—Parkinson's disease	0.00807	0.00807	CbGpPWpGaD
Imiquimod—CYP1A2—Estrogen metabolism—GSTM1—Parkinson's disease	0.00804	0.00804	CbGpPWpGaD
Imiquimod—CYP1A2—Melatonin metabolism and effects—CYP2D6—Parkinson's disease	0.00792	0.00792	CbGpPWpGaD
Imiquimod—CYP3A4—Tamoxifen metabolism—CYP2D6—Parkinson's disease	0.00791	0.00791	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—TNF—Parkinson's disease	0.00781	0.00781	CbGpPWpGaD
Imiquimod—TLR8—Immune System—HLA-DRA—Parkinson's disease	0.00758	0.00758	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—TNF—Parkinson's disease	0.00758	0.00758	CbGpPWpGaD
Imiquimod—CYP3A4—Xenobiotics—CYP2E1—Parkinson's disease	0.00752	0.00752	CbGpPWpGaD
Imiquimod—TLR8—Immune System—PLA2G6—Parkinson's disease	0.0075	0.0075	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—MAPK8—Parkinson's disease	0.00748	0.00748	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—MAPK8—Parkinson's disease	0.00739	0.00739	CbGpPWpGaD
Imiquimod—CYP1A2—Tryptophan metabolism—MAOB—Parkinson's disease	0.00737	0.00737	CbGpPWpGaD
Imiquimod—CYP3A4—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.00724	0.00724	CbGpPWpGaD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—Parkinson's disease	0.00701	0.00701	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—ABL1—Parkinson's disease	0.00699	0.00699	CbGpPWpGaD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—IL6—Parkinson's disease	0.00688	0.00688	CbGpPWpGaD
Imiquimod—TLR8—Immune System—PARK2—Parkinson's disease	0.00685	0.00685	CbGpPWpGaD
Imiquimod—TLR8—Immune System—FGF20—Parkinson's disease	0.00679	0.00679	CbGpPWpGaD
Imiquimod—CYP3A4—Estrogen metabolism—COMT—Parkinson's disease	0.00678	0.00678	CbGpPWpGaD
Imiquimod—CYP3A4—Tryptophan metabolism—DDC—Parkinson's disease	0.00675	0.00675	CbGpPWpGaD
Imiquimod—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—Parkinson's disease	0.00669	0.00669	CbGpPWpGaD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—IL6—Parkinson's disease	0.00664	0.00664	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—ADRBK1—Parkinson's disease	0.0065	0.0065	CbGpPWpGaD
Imiquimod—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.00638	0.00638	CbGpPWpGaD
Imiquimod—TLR7—Immune System—DCTN1—Parkinson's disease	0.00632	0.00632	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—IL6—Parkinson's disease	0.0063	0.0063	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—IL6—Parkinson's disease	0.00623	0.00623	CbGpPWpGaD
Imiquimod—CYP3A4—Estrogen metabolism—GSTM1—Parkinson's disease	0.0062	0.0062	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—IL6—Parkinson's disease	0.00612	0.00612	CbGpPWpGaD
Imiquimod—CYP1A2—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.00596	0.00596	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—TNF—Parkinson's disease	0.00592	0.00592	CbGpPWpGaD
Imiquimod—TLR7—Immune System—HLA-DRA—Parkinson's disease	0.00575	0.00575	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PLA2G6—Parkinson's disease	0.00569	0.00569	CbGpPWpGaD
Imiquimod—CYP3A4—Tryptophan metabolism—MAOB—Parkinson's disease	0.00568	0.00568	CbGpPWpGaD
Imiquimod—CYP1A2—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.00555	0.00555	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—ABL1—Parkinson's disease	0.0053	0.0053	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PARK2—Parkinson's disease	0.00519	0.00519	CbGpPWpGaD
Imiquimod—TLR7—Immune System—FGF20—Parkinson's disease	0.00515	0.00515	CbGpPWpGaD
Imiquimod—CYP1A2—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.00501	0.00501	CbGpPWpGaD
Imiquimod—TLR8—Immune System—ADRBK1—Parkinson's disease	0.00499	0.00499	CbGpPWpGaD
Imiquimod—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.00498	0.00498	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—NQO1—Parkinson's disease	0.00495	0.00495	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NQO1—Parkinson's disease	0.00495	0.00495	CbGpPWpGaD
Imiquimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.00492	0.00492	CbGpPWpGaD
Imiquimod—CYP1A2—Phase II conjugation—GSTA4—Parkinson's disease	0.00492	0.00492	CbGpPWpGaD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00483	0.00483	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—IL6—Parkinson's disease	0.00478	0.00478	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—IL6—Parkinson's disease	0.00472	0.00472	CbGpPWpGaD
Imiquimod—CYP1A2—Melatonin metabolism and effects—APOE—Parkinson's disease	0.00452	0.00452	CbGpPWpGaD
Imiquimod—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00443	0.00443	CbGpPWpGaD
Imiquimod—CYP1A2—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00437	0.00437	CbGpPWpGaD
Imiquimod—TLR8—Immune System—ABL1—Parkinson's disease	0.00407	0.00407	CbGpPWpGaD
Imiquimod—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00405	0.00405	CbGpPWpGaD
Imiquimod—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.00403	0.00403	CbGpPWpGaD
Imiquimod—CYP1A2—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00399	0.00399	CbGpPWpGaD
Imiquimod—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.00386	0.00386	CbGpPWpGaD
Imiquimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.00384	0.00384	CbGpPWpGaD
Imiquimod—TLR8—Immune System—HGF—Parkinson's disease	0.00383	0.00383	CbGpPWpGaD
Imiquimod—TLR7—Immune System—ADRBK1—Parkinson's disease	0.00378	0.00378	CbGpPWpGaD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.00373	0.00373	CbGpPWpGaD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00359	0.00359	CbGpPWpGaD
Imiquimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.00342	0.00342	CbGpPWpGaD
Imiquimod—CYP1A2—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.0034	0.0034	CbGpPWpGaD
Imiquimod—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.00337	0.00337	CbGpPWpGaD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00328	0.00328	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—MAPK8—Parkinson's disease	0.00316	0.00316	CbGpPWpGaD
Imiquimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.00312	0.00312	CbGpPWpGaD
Imiquimod—TLR7—Immune System—ABL1—Parkinson's disease	0.00308	0.00308	CbGpPWpGaD
Imiquimod—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00308	0.00308	CbGpPWpGaD
Imiquimod—TLR7—Immune System—HGF—Parkinson's disease	0.0029	0.0029	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—GSTA4—Parkinson's disease	0.00288	0.00288	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00284	0.00284	CbGpPWpGaD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.00277	0.00277	CbGpPWpGaD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.0027	0.0027	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—MAOB—Parkinson's disease	0.00256	0.00256	CbGpPWpGaD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00253	0.00253	CbGpPWpGaD
Imiquimod—CYP1A2—Phase II conjugation—COMT—Parkinson's disease	0.00247	0.00247	CbGpPWpGaD
Imiquimod—CYP1A2—Phase II conjugation—GSTP1—Parkinson's disease	0.00246	0.00246	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—MAPK8—Parkinson's disease	0.0024	0.0024	CbGpPWpGaD
Imiquimod—CYP1A2—Phase II conjugation—GSTM1—Parkinson's disease	0.00226	0.00226	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.00222	0.00222	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00219	0.00219	CbGpPWpGaD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00208	0.00208	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—IL6—Parkinson's disease	0.00202	0.00202	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL1B—Parkinson's disease	0.00201	0.00201	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	0.00199	0.00199	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.00198	0.00198	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—CYP2D6—Parkinson's disease	0.00191	0.00191	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.00188	0.00188	CbGpPWpGaD
Imiquimod—TLR8—Immune System—MAPK8—Parkinson's disease	0.00184	0.00184	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—CYP2E1—Parkinson's disease	0.00174	0.00174	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00172	0.00172	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.00159	0.00159	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—IL6—Parkinson's disease	0.00153	0.00153	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL1B—Parkinson's disease	0.00152	0.00152	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	0.00147	0.00147	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.00145	0.00145	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—COMT—Parkinson's disease	0.00144	0.00144	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	0.00144	0.00144	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	0.00144	0.00144	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	0.00144	0.00144	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	0.00143	0.00143	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	0.00142	0.00142	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	0.00142	0.00142	CbGpPWpGaD
Imiquimod—TLR7—Immune System—MAPK8—Parkinson's disease	0.0014	0.0014	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.00135	0.00135	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.00133	0.00133	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	0.00132	0.00132	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	0.0013	0.0013	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL6—Parkinson's disease	0.00118	0.00118	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—COMT—Parkinson's disease	0.00111	0.00111	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	0.00111	0.00111	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	0.00111	0.00111	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	0.0011	0.0011	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	0.00109	0.00109	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	0.00102	0.00102	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	0.00101	0.00101	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000995	0.000995	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ND3—Parkinson's disease	0.000937	0.000937	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—MCCC1—Parkinson's disease	0.000937	0.000937	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL6—Parkinson's disease	0.000891	0.000891	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—OMD—Parkinson's disease	0.000881	0.000881	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—TALDO1—Parkinson's disease	0.000881	0.000881	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	0.000835	0.000835	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GCH1—Parkinson's disease	0.000796	0.000796	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—MCCC1—Parkinson's disease	0.000723	0.000723	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ND3—Parkinson's disease	0.000723	0.000723	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000718	0.000718	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—FBP1—Parkinson's disease	0.00071	0.00071	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—DBH—Parkinson's disease	0.00071	0.00071	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GBA—Parkinson's disease	0.00071	0.00071	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—TALDO1—Parkinson's disease	0.00068	0.00068	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—OMD—Parkinson's disease	0.00068	0.00068	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	0.000644	0.000644	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GCH1—Parkinson's disease	0.000615	0.000615	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—DBH—Parkinson's disease	0.000548	0.000548	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—FBP1—Parkinson's disease	0.000548	0.000548	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GBA—Parkinson's disease	0.000548	0.000548	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—DDC—Parkinson's disease	0.000521	0.000521	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTA4—Parkinson's disease	0.000492	0.000492	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000486	0.000486	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	0.000443	0.000443	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—MAOB—Parkinson's disease	0.000439	0.000439	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000417	0.000417	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—DDC—Parkinson's disease	0.000402	0.000402	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTA4—Parkinson's disease	0.00038	0.00038	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	0.000342	0.000342	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—MAOB—Parkinson's disease	0.000338	0.000338	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	0.000326	0.000326	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CTGF—Parkinson's disease	0.00032	0.00032	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	0.000298	0.000298	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NQO1—Parkinson's disease	0.000295	0.000295	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—TH—Parkinson's disease	0.000291	0.000291	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYCS—Parkinson's disease	0.000279	0.000279	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	0.000252	0.000252	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—COMT—Parkinson's disease	0.000247	0.000247	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CTGF—Parkinson's disease	0.000247	0.000247	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTP1—Parkinson's disease	0.000246	0.000246	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—MAOA—Parkinson's disease	0.000245	0.000245	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—HMOX1—Parkinson's disease	0.000242	0.000242	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ABCB1—Parkinson's disease	0.000233	0.000233	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	0.00023	0.00023	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NQO1—Parkinson's disease	0.000227	0.000227	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTM1—Parkinson's disease	0.000226	0.000226	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—TH—Parkinson's disease	0.000224	0.000224	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GPX1—Parkinson's disease	0.000216	0.000216	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYCS—Parkinson's disease	0.000215	0.000215	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—MTHFR—Parkinson's disease	0.0002	0.0002	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—COMT—Parkinson's disease	0.000191	0.000191	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTP1—Parkinson's disease	0.00019	0.00019	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—MAOA—Parkinson's disease	0.000189	0.000189	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—HMOX1—Parkinson's disease	0.000187	0.000187	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—APOE—Parkinson's disease	0.000186	0.000186	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ABCB1—Parkinson's disease	0.00018	0.00018	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTM1—Parkinson's disease	0.000174	0.000174	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GPX1—Parkinson's disease	0.000167	0.000167	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—INS—Parkinson's disease	0.000159	0.000159	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—MTHFR—Parkinson's disease	0.000154	0.000154	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—APOE—Parkinson's disease	0.000143	0.000143	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—INS—Parkinson's disease	0.000123	0.000123	CbGpPWpGaD
